cerrar
Tagged with Research

Frédéric Collet – President Novartis France and General…
Frédéric Collet, president Novartis France and general manager oncology explains the rationale behind Novartis’s consistent investment in…

The 5 Most Influential Medical Research Charities in the UK
An unusual characteristic of the UK's healthcare landscape is that charities fund the vast majority of medical research.  According to…

Dae Jung Kim – President, Daiichi Sankyo Korea
Dae Jung Kim, president of Daiichi Sankyo Korea provides an insight into the rationale behind the company’s focus on the cardiovascular therapeutic…

Jesús Fernández-Pacheco Mena – Country Manager, hmR Spain
Jesús Fernández-Pacheco Mena, country manager of hmR Spain, a health market research specialist, highlights the innovative “sell out” model of…

PJ Brooks – Program Officer, Division of Clinical Innovation…
PJ Brooks PhD, program director in the Office of Rare Diseases Research at the National Center for Advancing Translational Sciences (NCATS), National…

Joan Puig de Dou – CEO, Kymos Pharma, Spain
Joan Puig de Dou, CEO of Kymos Pharma, a Spanish analytical CRO, shares his insights in the changing dynamics of the industry and explains how…

Alexander Eggermont – General Director, Gustave Roussy,…
Professor Alexander Eggermont, general director of Gustave Roussy, gives insights into the transformation of the Hospital under his ten-year…

Korea: Prioritising AI in Healthcare Innovation
The South Korean government has designated the promotion of artificial intelligence (AI)-based drug development and healthcare innovation as a…

Luis Serrano – President, Centre for Genomic Regulation…
Luis Serrano, president of the Centre for Genomic Regulation (CRG) in Spain, gives an update on the Centre’s recent history and outlines the need…

Young-Jack Lee – CEO, LSK Global PS, South Korea
Young Jack Lee, CEO of LSK Global PS, Korea’s largest local contract research organization (CRO) gives his insights on the evolution of the clinical…

Kyungjin Peter Kim – CEO, ST Pharm, South Korea
Kyungjin Peter Kim, CEO of ST Pharm, provides an insight into his expansion of the company’s operations from simply a CMO into a CDMO and new drug…

Kang Wei – Managing Director, RDPAC, China
Kang Wei, managing director for the R&D-based Pharmaceutical Association Committee (RDPAC) under the China Association of Enterprises with Foreign…
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here